MAPT and Alzheimer disease: The clinical symptoms of AD may be characterized by progressive cognitive decline, accompanied by senile plaques composed of β-amyloid peptide (Aβ) and neurofibrillary tangles composed of hyperphosphorylated tau (Anandatheerthavarada et al., 2003).